(SXRV) iShares NASDAQ 100 USD - Ratings and Ratios
Technology, Consumer, Healthcare
Description: SXRV iShares NASDAQ 100 USD
The iShares NASDAQ100 UCITS ETF USD (Acc) (XETRA:SXRV) is an exchange-traded fund that tracks the Morningstar US LM Brd Growth NR USD index, providing investors with exposure to US large-cap growth equities. As a UCITS-compliant ETF, it adheres to strict regulatory standards, making it a viable option for a wide range of investors.
With its domicile in Germany and listing on XETRA, SXRV offers a diversified portfolio that is heavily weighted towards technology and growth-oriented stocks, mirroring the composition of the NASDAQ-100 index. Although the funds prospectus and holdings are not explicitly detailed here, it is reasonable to infer that its constituents are predominantly made up of large-cap US companies with strong growth profiles, such as those in the technology, communication services, and consumer discretionary sectors.
Analyzing the provided technical data, we observe that the ETFs last price is 1093.40, with various moving averages indicating a potential trend. The SMA20 and SMA200 are closely aligned, suggesting a stable trend, while the SMA50 is significantly lower, indicating a potential support level. The ATR of 18.46 (1.69%) implies a moderate level of volatility. Given these indicators, a likely forecast is that the ETF will continue to trade within a narrow range, potentially consolidating before making its next move.
Combining the technical analysis with fundamental data, such as the AUM of 6445.87M EUR, we can infer that SXRV is a sizable and liquid ETF, capable of absorbing significant trading volumes without substantial price movements. This, coupled with its tracking of a well-established index, positions the ETF for potential long-term growth, driven by the underlying performance of its constituent stocks. A forecast based on both technical and fundamental analysis suggests that SXRV may experience a gradual appreciation in value, potentially reaching new highs as the underlying NASDAQ-100 constituents continue to grow and expand.
Forecasting the future performance of SXRV involves considering both the macroeconomic environment and the specific characteristics of the NASDAQ-100 index. Assuming a continued favorable environment for US large-cap growth stocks, and given the ETFs diversified holdings and sizable AUM, a plausible short-term target could be in the range of 1150-1200, representing a 5-10% increase from current levels. However, this forecast is contingent upon a stable or improving macroeconomic backdrop and the absence of significant market disruptions.
Additional Sources for SXRV ETF
SXRV ETF Overview
Market Cap in USD | 7,605m |
Category | US Large-Cap Growth Equity |
TER | 0.30% |
IPO / Inception | 2010-01-26 |
SXRV ETF Ratings
Growth Rating | 66.4 |
Fundamental | - |
Dividend Rating | 0.0 |
Rel. Strength | -8.66 |
Analysts | - |
Fair Price Momentum | 1039.27 EUR |
Fair Price DCF | - |
SXRV Dividends
Currently no dividends paidSXRV Growth Ratios
Growth Correlation 3m | 84% |
Growth Correlation 12m | 23.9% |
Growth Correlation 5y | 86.5% |
CAGR 5y | 15.53% |
CAGR/Max DD 5y | 0.50 |
Sharpe Ratio 12m | 0.00 |
Alpha | -12.18 |
Beta | 1.029 |
Volatility | 14.51% |
Current Volume | 7.1k |
Average Volume 20d | 6.6k |
As of July 03, 2025, the stock is trading at EUR 1099.80 with a total of 7,081 shares traded.
Over the past week, the price has changed by +0.40%, over one month by +2.88%, over three months by +6.86% and over the past year by +3.89%.
Yes. Based on ValueRay's Analyses, iShares NASDAQ 100 USD (XETRA:SXRV) is currently (July 2025) a good stock to buy. It has a ValueRay Growth Rating of 66.40 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of SXRV is around 1039.27 EUR . This means that SXRV is currently overvalued and has a potential downside of -5.5%.
iShares NASDAQ 100 USD has no consensus analysts rating.
According to our own proprietary Forecast Model, SXRV iShares NASDAQ 100 USD will be worth about 1221.4 in July 2026. The stock is currently trading at 1099.80. This means that the stock has a potential upside of +11.05%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 1221.4 | 11.1% |